FDA Orange Book · active-ingredient family
Piperacillin sodium
Piperacillin sodium is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:PIPRACIL · NDA 050545
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PIPRACILRLD×4 | WYETH PHARMS INC | NDA 050545 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PIPERACILLIN | ISTITUTO BIO ITA SPA | ANDA 065157 | — | Jul 12, 2004 | |
| PIPERACILLIN×3 | ISTITUTO BIO ITA SPA | ANDA 065114 | — | Nov 14, 2003 | |
| PIPRACIL×3 | WYETH PHARMS INC | ANDA 062750 | — | Oct 13, 1987 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Piperacillin sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

